AI CAPITAL INTELLIGENCE
睿心医疗 funding history
1 recorded financing disclosures for 睿心医疗. Dates, rounds, currencies and original sources follow the individual records. This is not a complete company funding history.
Latest recorded funding, at a glance
The latest disclosure recorded for 睿心医疗 is dated 2026-05-27: Series D, Approximately CNY 100,000,000. Named investors: 广州生物医药与健康产业投资有限公司, 广州越富基金管理有限公司, 广州健康产投, 越富基金. This is the latest record in our coverage, not a claim about all company financing.
Verify this disclosure · Original source 1 · Original source 2 · Original source 3 · Original source 4 · Original source 5 · Original source 6
Disclosures and evidence
| Disclosure date | Round | Disclosed amount | Named investors | Evidence |
|---|---|---|---|---|
| Series D | Approximately CNY 100,000,000 | 广州生物医药与健康产业投资有限公司, 广州越富基金管理有限公司, 广州健康产投, 越富基金 | Record · Source 1 · Source 2 · Source 3 · Source 4 · Source 5 · Source 6 |
Recorded financing disclosures
- 睿心医疗2026-05-27 · Series D · Approximately CNY 100,000,000
Disclosed investors across recorded rounds
Publicly disclosed founding team
- 郑凌霄 (Chinese) · 创始人&CEO
- 马骏 (Chinese) · 联合创始人&CTO
- 兰宏志 (Chinese) · 联合创始人&首席科学家